v3.26.1
Condensed Consolidated Statements of Cash Flows - USD ($)
$ in Thousands
 3 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (60,618) $ (33,940)
Non-cash adjustments to reconcile net loss to net cash used operating activities:    
Stock-based compensation expense 7,423 5,298
Depreciation and amortization expense 397 280
Accretion on investments, net of amortization (990) (1,961)
Other non-cash items 245 (4)
Changes in operating assets and liabilities:    
Accounts receivable (839) (1,128)
Inventories (294) (8,449)
Prepaid expenses and other assets (524) (4,796)
Accounts payable and accrued liabilities 10,315 4,168
Contract liability (61) (210)
Net cash and cash equivalents used in operating activities (44,946) (40,742)
Cash flows from investing activities:    
Purchases of short-term investments, available-for-sale (14,709) (34,345)
Maturities of short-term investments, available-for-sale 42,500 63,500
Purchases of property and equipment 0 (91)
Net cash and cash equivalents provided by investing activities 27,791 29,064
Cash flows from financing activities:    
Proceeds from royalties earned under license agreements recognized as an increase to the financing liability 97 0
Proceeds from exercise of common stock options and issuance of common stock under the employee stock purchase plan 62 725
Net cash and cash equivalents provided by financing activities 159 725
Net decrease in cash and cash equivalents (16,996) (10,953)
Cash and cash equivalents at beginning of period 41,317 50,817
Cash and cash equivalents at end of period 24,321 39,864
Supplemental cash flow information:    
Cash paid for interest 2,293 0
Noncash Investing and Financing Items [Abstract]    
Financing liability in accounts receivable $ 2,533 $ 0